a b s t r a c t We present a case of Tricuspid valve Aspergillus endocarditis with saddle shaped massive pulmonary embolism occurring in an immunocompetent host. The patient was managed uniquely by pulmonary endarterectomy (PEA) and combination antifungal chemotherapy with Liposomal amphotericin-B þ caspofungin.
Introduction
Fungal endocarditis is uncommon and accounts for less than 10% of all cases of infective endocarditis. Fungal endocarditis is related usually to intravenous drug abuse, cardiac prosthesis or an immunocompromised state. Aspergillus species causes approximately 20e30% of all fungal endocarditis cases while rests of the cases are contributed usually by Candida species. 1 Here we present the case of complicated right sided Aspergillus endocarditis in an immune host that was encouragingly managed by synergistic antifungal drugs and PEA.
Case report
A 23-year-old female was referred for cardiac evaluation in view of moderate to high grade fever since past 1 month and worsening dyspnea from New York heart association (NYHA) class II to NYHA class IV over the past 15 days. The patient's temperature was 101 F and blood pressure was 100/48 mm Hg. Her heart rate and respiratory rate were 110 beats/min and 28/min respectively. On physical examination the patient had pallor and a prominent VeY descent waveform in Jugular venous pulse. No clubbing, or peripheral stigmata of endocarditis were present on physical examination. The resting oxygen saturation on room air was 85%. The patient denied any history suggestive of congenital heart disease in childhood; steroid abuse and intravenous (i.v.) drug abuse. Her hemoglobin was low (9.0 g/dL), white blood cell count was normal (10,400/mm 3 ) but demonstrated a left shift (72% neutrophils and 14% bands) and platelet count was 105,000/mm 3 . Other biochemical investigations were within normal limits. A transthoracic echocardiography (TTE) revealed:
1. Dilated right atrium, right ventricle, and large (~2.5 Â 2.0 cm) mobile vegetation attached to the septal leaflet of the tricuspid valve causing severe regurgitation ( Fig 1A) . After obtaining multiple blood samples for cultures, the patient was started on empiric vancomycin and amikacin. Patient then underwent spiral chest computed tomography with contrast enhancement that showed filling defects in MPA and its bifurcation by a saddle shaped thrombus (Fig 2A) . An alveolar opacity was noted in the lower left lung parenchyma suggestive of consolidation with syn-pneumonic effusion. The patient was then shifted for emergency surgery.
3.
Surgical and postoperative course 1. Upon Oblique right atriotomy, multiple friable vegetations were found on tricuspid valve, with thickening and destruction of leaflet tissue (Fig. 2B ). Tricuspid valvulectomy with annular debridement was done. Right ventriculotomy with outflow tract incision extending transannularly into MPA was given. After pulmonary valvulectomy and annular debridement, thrombus cast adherent to the MPA and branch pulmonary artery was removed with endarterctomy by creating a dissection plane between intima and the media (Fig. 2C, D) . VSD was closed with pericardial patch. Pulmonary and tricuspid valves were replaced by Carpentier-Edwards porcine bioprosthetic valve with 27 mm and 33 mm diameter respectively. Excised specimen pathology revealed mononuclear infiltrate with tissue invasion by branching fungi having septate hyphae consistent with filamentous Aspergillus species. Culture of the infected tissue showed the growth of Aspergillus fumigatus. Antibiotic was then changed to Liposomal Amphotericin-B (3 mg/kg/day). However the patient continued to have fever in the postoperative course, so a week later caspofungin (70 mg on day 1 followed by 50 mg daily thereafter as i.v. infusion) was added for the next 4 weeks. The patient subsequently became afebrile, discharged and now continues to demonstrate good functional capacity, normal cell counts and no disease recurrence in her clinical and echo follow up since past one year.
Discussion
The optimal treatment approach for fungal endocarditis requires aggressive surgical debridement in conjunction with antifungal therapy. Our patient presentation, echocardiographic findings and subsequent management were unique on the following grounds:
1. Congenital heart disease is a substrate for infective endocarditis in 10e20% of young adults. The absence of neutropenia; steroid abuse; intravenous drug abuse; lymphoid or leukemic disease led us to the presumption of normal immune status of the patient with VSD being the only predisposing defect. A recently published case report also describes A. fumigatus endocarditis in an immunocompetent patient. 2 The resting desaturation on presentation can be explained by near systemic right sided pressure with bidirectional shunting across VSD or ventilation-perfusion mismatch arising out of lung infection. 2. Severe pulmonary stenosis arising out of a fungal thrombus adherent to MPA and proximal branches was a unique finding. A case report describes similar scenario when the Melody percutaneous valve implanted for pulmonary homograft constriction got occluded by a massive pulmonary fungal thrombus of Aspergillus origin that was removed by embolectomy. 3 TEE was not done because as a cost effective approach, we do TEE in only those patients who have poor echo window, prosthetic valves or a negative TTE with a high index of clinical suspicion. 3. As the fungal thrombus was adherent to the intima of pulmonary vasculature so it was decided to perform PEA which is a well-established procedure in the treatment of chronic thromboembolic pulmonary hypertension rather. There is a single report of PEA in infectious pulmonary embolism thus making our surgical management unique. 4 While this report does not recommend PEA due to inability to find a cleavage plane, we were able to dissect into the intimal layer. With endarterectomy we were able to remove the vegetation enbloc while an attempt at piecemeal removal would have resulted in embolisation or incomplete debridement. As the vegetation cast also extended into the bifurcation we could not resort to the technique of pulmonary root replacement that is described for isolated pulmonary valve endocarditis. 5 4. Voriconazole is approved for first-line therapy in Invasive aspergillosis. 6 Not only because of availability in our set up, we used the combination of liposomal amphotericin B and caspofungin with the rationale of achieving synergism by inhibition of fungal cell wall biosynthesis by caspofungin and loss of fungal cell membrane integrity by amphotericin B. A recent prospective study also showed promising results with such combination in invasive aspergillosis compared with monotherapy in immunocompromised patients. 7 
5.

Conclusion
An immunocompetent host, aggressive surgical debridement and combination antifungal therapy for invasive aspergillosis resulted in favorable prognosis in our patient. Large vegetation can embolise to the pulmonary vasculature creating severe pulmonary stenosis that requires emergency removal by embolectomy or endarterectomy.
